Lymphocyte reconstitution following autologous stem cell transplantation for progressive MS

por Cull, G, Hall, D, Fabis-Pedrini, MJ, Carroll, WM, Forster, L, Robins, F, Ghassemifar, R, Crosbie, C, Walters, S, James, I, Augustson, B, Kermode, AK
Publicado 2017

P1176: RITUXIMAB IN PRIMARY CNS LYMPHOMA – LONG TERM FOLLOW-UP OF THE PHASE III HOVON 105/ALLG NHL 24 STUDY

por Doorduijn, J., Issa, S., van der Holt, B., Minnema, M., Seute, T., Durian, M., Cull, G., van der Poel, M., Stevens, W., Zijlstra, J., Nijland, M., Mason, K., Beeker, A., Brandsma, D., van den Bent, M., Gonzalez, M., de Jong, D., Bromberg, J.
Publicado 2022

P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RANDOMIZED TRIAL OF ZANUBRUTINIB (ZANU) VS IBRUTINIB (IBR) IN PATIENTS (PTS) WITH WALDENSTRÖM MACROGLOBULINEMIA (WM)

por Dimopoulos, M., Opat, S., D’Sa, S., Jurczak, W., Lee, H.-P., Cull, G., Owen, R. G., Marlton, P., Wahlin, B. E., Garcia-Sanz, R., McCarthy, H., Mulligan, S., Tedeschi, A., Castillo, J. J., Czyz, J., Fernandez De Larrea Rodriguez, C., Belada, D., Libby, E., Matous, J., Motta, M., Siddiqi, T., Tani, M., Trneny, M., Minnema, M., Buske, C., Leblond, V., Treon, S. P., Trotman, J., Chan, W. Y., Schneider, J., Allewelt, H., Cohen, A., Huang, J., Tam, C. S.
Publicado 2022